Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2000, p. 2574-2578, Vol. 38, No. 7
Magee-Women's Research
Institute1 and Department of Pathology,
University of Pittsburgh,2 Pittsburgh,
Pennsylvania 15213
Received 30 December 1999/Returned for modification 10 February
2000/Accepted 10 May 2000
Ten percent of infants born in the United States are admitted to
neonatal intensive care units (NICU) annually. Approximately one-half
of these admissions are from term infants (>34 weeks of gestation) at
risk for systemic infection. Most of the term infants are not infected
but rather have symptoms consistent with other medical conditions that
mimic sepsis. The current standard of care for evaluating bacterial
sepsis in the newborn is performing blood culturing and providing
antibiotic therapy while awaiting the 48-h preliminary result of
culture. Implementing a more rapid means of ruling out sepsis in term
newborns could result in shorter NICU stays and less antibiotic usage.
The purpose of this feasibility study was to compare the utility of PCR
to that of conventional culture. To this end, a total of 548 paired
blood samples collected from infants admitted to the NICU for suspected
sepsis were analyzed for bacterial growth using the BACTEC 9240 instrument and for the bacterial 16S rRNA gene using a PCR assay which
included a 5-h preamplification culturing step. The positivity rates by
culture and PCR were 25 (4.6%) and 27 (4.9%) positive specimens out
of a total of 548 specimens, respectively. The comparison revealed sensitivity, specificity, and positive and negative predictive values
of 96.0, 99.4, 88.9, and 99.8%, respectively, for PCR. In summary,
this PCR-based approach, requiring as little as 9 h of turnaround
time and blood volumes as small as 200 µl, correlated well with
conventional blood culture results obtained for neonates suspected of
having bacterial sepsis.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Comparison of 16S rRNA Gene PCR and BACTEC 9240 for
Detection of Neonatal Bacteremia
*
Corresponding author. Mailing address: Magee-Women's
Research Institute, 204 Craft Ave., Laboratory 440, Pittsburgh, PA
15213. Phone: (412) 641-4104. Fax: (412) 641-6156. E-mail:
jordanja+{at}pitt.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|